Regeneron Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Okay. Welcome to the afternoon sessions of the BofA Virtual Vegas Global Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here, and I have Alec Stranahan from my team on the line as well.
And we're thrilled to have Regeneron for a session today. And with us today, we have CFO, Bob Landry; and Head of Commercial, Marion McCourt. Bob, Marion, welcome. We also have Justin Holko from the IR.
Hey, guys.
Hey, Geoff. Thanks. Good afternoon, everyone. Thanks for joining us today. And Geoff and Alec, thanks for inviting us to your conference. We always look forward to attend the annual conference. This year's virtual, but I'm sure we'll be in person next year. Happy to be there.
So before we begin, let me remind everyone that remarks made in the webcast include forward-looking statements about Regeneron. Each forward-looking statement is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |